Thursday, May 29, 2014
Publication and contact
Modeling effects of mutant huntingtin
pathology with a conditional transgenic mouse model
how mutant HTT expression in different cell populations affects Huntington's
disease (HD) pathology could provide new therapeutic insights on how to treat
HD. In a conditional transgenic mouse model of HD, selectively decreasing
mutant Htt expression in cortical neurons led to less severe HD-associated
motor and behavioral deficits compared with baseline but did not attenuate
neurodegeneration. In the mouse model, decreasing mutant Htt expression in
both cortical and striatal neurons resulted in less neurodegeneration and
less severe HD-associated motor and behavioral deficits compared with
baseline. Next steps include studying cell-autonomous mechanisms of mutant
HTT toxicities in the cortical and striatal neuronal cell types and
elucidating the molecular basis of non-cell-autonomous interactions between
the two neurons that result in toxicity.
Published online May 29, 2014
Model unpatented; licensed
to CHDI Foundation Inc. and several
Wang, N. et al. Nat.
Med.; published online April 28, 2014;
Contact: X. William Yang, University of California,
Los Angeles, Calif.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]